The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the
"Company”), a leading high-growth platform of better-for-you
beverage brands, today announced financial results for the third
quarter ended September 30, 2023.
Third Quarter
2023 Highlights Compared to Prior-Year
Period
- Net sales grew by 11% to $138 million driven by strong 8% net
sales growth and 5% volume growth of Vita Coco Coconut Water which
continues to be the largest contributor to growth on a consolidated
basis.
- Gross profit was $56 million, or 41% of net sales, an
increase of $24 million as compared to 26% of net sales in the
prior-year period with the improvement driven by lower
year-over-year transportation costs, net sales growth and higher
Vita Coco Coconut Water pricing.
- Net income was $15 million, or $0.26 per diluted share,
compared to $7 million, or $0.13 per diluted share. Net income
benefited from strong net sales growth and gross margin improvement
resulting primarily from decreased transportation costs, partially
offset by increased investments in sales, general and
administrative ("SG&A") and a mark-to-market adjustment in
foreign currency hedges.
- Non-GAAP Adjusted EBITDA1 was $27 million, compared to $12
million in the prior-year period, up $15 million due to
improvements in gross profit partially offset by increased SG&A
spending.
2023 Year-To-Date
Highlights Compared to Prior-Year Period
- Net sales grew 15% to $387 million driven by strong 16% net
sales growth and 13% volume growth of Vita Coco Coconut Water which
continues to be the largest contributor to growth on a consolidated
basis.
- Gross profit was $141 million, or 36% of net sales, an increase
of $60 million as compared to 24% of net sales in the prior-year
period, with the increase driven primarily by lower year-over-year
transportation costs, net sales growth and increased Vita Coco
Coconut Water pricing.
- Net income was $40 million, or $0.68 per diluted share,
compared to $11 million, or $0.19 per diluted share, in the
prior-year period with the increase driven by strong net sales
growth and gross margin improvement resulting primarily from
decreased transportation costs, partially offset by increased
investments in SG&A, a mark-to-market adjustment in foreign
currency hedges, and increased tax expense.
- Non-GAAP Adjusted EBITDA1 was $60 million, compared to $16
million in the prior-year period due to improvements in gross
profit partially offset by increased SG&A spending.
Michael Kirban, the Company's Co-Founder and
Executive Chairman, stated, "I am very proud of our team and its
continued strong performance this year. We have delivered another
strong quarter and we believe that our focus on expanding
consumption occasions for coconut water is contributing to strong
volume performance for our flagship Vita Coco Coconut Water brand.
The organization's ability to drive incredible volume growth while
continuing to improve profitability and cash generation at the same
time is something that every member of the team should be proud
of."
Martin Roper, the Company’s Chief Executive
Officer, said, "We are extremely pleased with this quarter's
results with 11% net sales growth and Adjusted EBITDA1 of $27
million. Gross margins for the quarter exceeded our expectations
due to better than expected price realization across our business,
and the stabilization of our transportation costs. We are raising
our full year net sales and Adjusted EBITDA1 guidance based on the
strong third quarter and an updated view on fourth quarter
shipments and product mix. We remain focused on investments to
support the health of our brands and drive sustainable long term
growth."
Third Quarter
2023 Consolidated Results
Net sales increased $14 million, or 11%, to $138
million for the third quarter ended September 30, 2023,
compared to $124 million for the third quarter ended
September 30, 2022. The increase in net sales was driven by
increased case equivalent ("CE") volumes coupled with some benefits
from net pricing actions on branded products partially offset by
price/mix of private label products.
Improved gross margins and gross profit versus
prior-year resulted from the reduction of transportation costs
coupled with increased branded pricing and increased sales volumes.
Gross profit was $56 million for the third quarter of 2023, which
was an increase of $24 million compared to the same prior-year
period. Gross margin of 41% in the third quarter represented a
sequential improvement of over 400 basis points from the second
quarter of 2023, and an increase of greater than 1400 basis points
from 26% in the same prior-year period.
SG&A expenses in the third quarter of 2023 were
$33 million, compared to $24 million in the prior-year period. The
increase was largely due to investments in marketing expenses and
higher personnel related expenses.
Net income was $15 million, or $0.26 per diluted
share, for the third quarter of 2023, compared to $7 million, or
$0.13 per diluted share in the third quarter of 2022. Net income
benefited from strong gross profit, partially offset by increased
SG&A investments, a non-cash mark-to-market loss in the fair
value of foreign currency hedges of $4 million versus a gain of $1
million last year and by an increase in tax expense of $2
million.
Non- GAAP Adjusted EBITDA1 for the third quarter of
2023 was $27 million, compared to $12 million in the prior-year
period. The increase in Adjusted EBITDA1 was primarily driven by
strong net sales growth and gross margin improvement resulting
primarily from decreased transportation costs and improved branded
pricing, partially offset by increased investments in SG&A.
Balance Sheet
As of September 30, 2023, the Company had cash
and cash equivalents of $95 million and no debt under its revolving
credit facility, compared to $20 million and no debt, as of
December 31, 2022. The increase in net cash was driven by improved
net income performance and reductions in working capital. On
September 30, 2023, there were 56,756,005 shares of common
stock outstanding.
On October 30, 2023, the Company's Board of
Directors approved a share repurchase program ("Program")
authorizing the Company to repurchase up to $40 million of the
Company's common stock. Shares of common stock may be repurchased
under the Program from time to time through open market purchases,
block trades, private transactions or accelerated or other
structured share repurchase programs.
Fiscal Year 2023
Full Year Outlook
The Company is updating its previously communicated
full year 2023 guidance:
- Expect net sales growth of
approximately 13-15% compared to fiscal year 2022 [previously
10-12%], based on mid teens Vita Coco Coconut Water growth and
strength in private label resulting from expanded distribution with
new and existing customers, plus our revised expectation of
retaining the majority of a key customer's private label coconut
water business.
- Full year gross margins in the range
of 35% to 37% [no change] benefiting from improved transportation
costs and branded pricing, partially offset by expected private
label price/mix impacts.
- Forecast Adjusted EBITDA2 in the range
of $64-67 million [previously $56-60 million] reflecting full year
net sales growth and gross margin improvement offset by increased
investment in SG&A to support the long term growth of the
company.
Management to provide an update on its private
label business and outlook during the earnings conference call
later today.
Footnotes:
(1) Adjusted EBITDA represents earnings before
interest, taxes, depreciation, and amortization, as adjusted for
certain items as set forth in the reconciliation table
of U.S. GAAP to non-GAAP information and is a measure
calculated and presented on the basis of methodologies other than
in accordance with GAAP. Please refer to the Use of Non-GAAP
Financial Information herein for further discussion and
reconciliation of this measure to GAAP measures.(2) GAAP Net Income
2023 outlook is not provided due to the inherent difficulty in
quantifying certain amounts due to a variety of factors, including
the unpredictability in the movement in foreign currency rates, as
well as future charges or reversals outside of the normal course of
business.
Conference Call and Webcast
Details
The Vita Coco Company will host a conference call
and webcast at 8:30 a.m. ET today to discuss these results. To
participate in the live earnings call and question and answer
session, please register
at https://register.vevent.com/register/BI1c04615dffc74402a2b94fb894e2f2b6 and
dial-in information will be provided directly to you. A slide
presentation to support the webcast, and the live audio webcast
will be accessible in the “Events” section of the Company’s
Investor Relations website at
https://investors.thevitacococompany.com. An archived replay of the
webcast will be available shortly after the live event has
concluded.
About The Vita Coco Company
The Vita Coco Company was co-founded in 2004 by
Chairman Michael Kirban and Ira Liran. Pioneers in the functional
beverage category, The Vita Coco Company’s brands include the
leading coconut water, Vita Coco; clean energy drink, Runa;
sustainable enhanced water, Ever & Ever; and protein-infused
water, PWR LIFT. With its ability to harness the power of people
and plants, and balance purpose and profit, The Vita Coco Company
has created a modern beverage platform built for current and future
generations.
The company is a Public Benefit Corporation in
Delaware and is a Certified B Corporation.™
ContactsInvestor Relations:
ICR, Inc.investors@thevitacococompany.com
Non-GAAP Financial Measures
In addition to disclosing results determined in
accordance with U.S. GAAP, the Company also discloses certain
non-GAAP results of operations, including, but not limited to,
Adjusted EBITDA, that include certain adjustments or exclude
certain charges and gains that are described in the reconciliation
table of U.S. GAAP to non-GAAP information provided at the end of
this release. These non-GAAP measures are a key metric used by
management and our board of directors to assess our financial
performance across reporting periods on a consistent basis by
excluding items that we do not believe are indicative of our core
operating performance and because we believe it is useful for
investors to see the measures that management uses to evaluate the
Company. In addition, we believe the presentation of these measures
is useful to investors for period-to-period comparisons of results
as the items described below in the reconciliation tables do not
reflect ongoing operating performance.
These measures are not in accordance with, or an
alternative to, U.S. GAAP, and may be different from non-GAAP
measures used by other companies. In addition, other companies,
including companies in our industry, may calculate such measures
differently, which reduces its usefulness as a comparative measure.
Investors should not rely on any single financial measure when
evaluating our business. This information should be considered as
supplemental in nature and is not meant as a substitute for our
operating results in accordance with U.S. GAAP. We recommend
investors review the U.S. GAAP financial measures included in this
earnings release. When viewed in conjunction with our U.S. GAAP
results and the accompanying reconciliations, we believe these
non-GAAP measures provide greater transparency and a more complete
understanding of factors affecting our business than U.S. GAAP
measures alone.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. All statements contained in this press release
that do not relate to matters of historical fact should be
considered forward-looking statements, including but not limited
to, statements regarding our future financial and operating
performance, including our GAAP and non-GAAP guidance, our
strategy, projected costs, prospects, expectations, plans,
objectives of management, supply chain predictions, customer and
supplier relationships and expected net sales and category share
growth.
The forward-looking statements in this release are
only predictions. We have based these forward-looking statements
largely on our current expectations and projections about future
events and financial trends that we believe may affect our
business, financial condition and results of operations.
Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that may cause our actual
results, performance or achievements to be materially different
from any future results, performance or achievements expressed or
implied by the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other
factors beyond the Company’s control. These factors include, but
are not limited to, those discussed under the caption “Risk
Factors” in our Annual Reports on Form 10-K, Quarterly Reports on
Form 10-Q and our other filings with the U.S. Securities and
Exchange Commission ("SEC") as such factors may be updated from
time to time and which are accessible on the SEC’s website at
www.sec.gov and the Investor Relations page of our website
at https://investors.thevitacococompany.com. Any
forward-looking statements contained in this press release speak
only as of the date hereof and accordingly undue reliance should
not be placed on such statements. We disclaim any obligation or
undertaking to update or revise any forward-looking statements
contained in this press release, whether as a result of new
information, future events or otherwise, other than to the extent
required by applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and
investors.thevitacococompany.com, as a means for disclosing
material non-public information and for complying with the SEC's
Regulation FD and other disclosure obligations.
THE VITA COCO COMPANY, INC. AND SUBSIDIARIES |
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED) |
(Amounts in thousands, except share data) |
|
|
September 30,2023 |
|
December 31,2022 |
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
94,885 |
|
|
$ |
19,629 |
|
Accounts receivable, net of allowance of $2,849 at
September 30, 2023, and $2,898 at December 31, 2022 |
|
79,577 |
|
|
|
43,350 |
|
Inventory |
|
50,380 |
|
|
|
84,115 |
|
Supplier advances |
|
1,525 |
|
|
|
1,534 |
|
Derivative assets |
|
3,147 |
|
|
|
3,606 |
|
Asset held for sale |
|
— |
|
|
|
503 |
|
Prepaid expenses and other current assets |
|
17,794 |
|
|
|
22,181 |
|
Total current assets |
|
247,308 |
|
|
|
174,918 |
|
Property and equipment, net |
|
2,225 |
|
|
|
2,076 |
|
Goodwill |
|
7,791 |
|
|
|
7,791 |
|
Supplier advances |
|
3,462 |
|
|
|
4,360 |
|
Deferred tax assets, net |
|
4,251 |
|
|
|
4,256 |
|
Right-of-use assets, net |
|
1,718 |
|
|
|
2,679 |
|
Other assets |
|
1,724 |
|
|
|
1,677 |
|
Total assets |
$ |
268,479 |
|
|
$ |
197,757 |
|
Liabilities and Stockholders’ Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
|
21,411 |
|
|
|
15,910 |
|
Accrued expenses and other current liabilities |
|
51,242 |
|
|
|
38,342 |
|
Notes payable, current |
|
15 |
|
|
|
23 |
|
Derivative liabilities |
|
1,371 |
|
|
|
71 |
|
Total current liabilities |
|
74,039 |
|
|
|
54,346 |
|
Notes payable, long-term |
|
15 |
|
|
|
25 |
|
Other long-term liabilities |
|
1,822 |
|
|
|
2,293 |
|
Total liabilities |
|
75,876 |
|
|
|
56,664 |
|
|
|
|
|
Stockholders’ equity: |
|
|
|
Common stock, $0.01 par value;
500,000,000 shares authorized; 62,962,205 and 62,225,250 shares
issued at September 30, 2023 and December 31, 2022, respectively;
56,756,005 and 56,019,050 Shares Outstanding at September 30, 2023
and December 31, 2022, respectively. |
|
629 |
|
|
|
622 |
|
Additional paid-in capital |
|
158,244 |
|
|
|
145,210 |
|
Retained earnings |
|
93,969 |
|
|
|
55,183 |
|
Accumulated other comprehensive loss |
|
(1,311 |
) |
|
|
(994 |
) |
Treasury stock, 6,206,200
shares at cost as of September 30, 2023, and December 31,
2022. |
|
(58,928 |
) |
|
|
(58,928 |
) |
Total stockholders’ equity attributable to The Vita Coco Company,
Inc. |
|
192,603 |
|
|
|
141,093 |
|
Total liabilities and stockholders’ equity |
$ |
268,479 |
|
|
$ |
197,757 |
|
THE VITA COCO COMPANY, INC. AND SUBSIDIARIES |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED) |
(Amounts in thousands, except for share and per share
data) |
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net sales |
$ |
138,064 |
|
|
$ |
124,043 |
|
|
$ |
387,468 |
|
|
$ |
335,796 |
|
Cost of goods sold |
|
81,893 |
|
|
|
91,467 |
|
|
|
246,542 |
|
|
|
254,868 |
|
Gross profit |
|
56,171 |
|
|
|
32,576 |
|
|
|
140,926 |
|
|
|
80,928 |
|
Operating expenses |
|
|
|
|
|
|
|
Selling, general and administrative |
|
32,649 |
|
|
|
23,960 |
|
|
|
89,855 |
|
|
|
73,018 |
|
Income (Loss) from operations |
|
23,522 |
|
|
|
8,616 |
|
|
|
51,071 |
|
|
|
7,910 |
|
Other income (expense) |
|
|
|
|
|
|
|
Unrealized gain/(loss) on derivative instruments |
|
(3,959 |
) |
|
|
952 |
|
|
|
(1,758 |
) |
|
|
6,416 |
|
Foreign currency gain/(loss) |
|
(1,211 |
) |
|
|
(364 |
) |
|
|
(430 |
) |
|
|
(508 |
) |
Interest income |
|
824 |
|
|
|
20 |
|
|
|
1,105 |
|
|
|
30 |
|
Interest expense |
|
(1 |
) |
|
|
(130 |
) |
|
|
(31 |
) |
|
|
(213 |
) |
Total other income (expense) |
|
(4,347 |
) |
|
|
478 |
|
|
|
(1,114 |
) |
|
|
5,725 |
|
Income before income taxes |
|
19,175 |
|
|
|
9,094 |
|
|
|
49,957 |
|
|
|
13,635 |
|
Income tax expense |
|
(4,011 |
) |
|
|
(1,836 |
) |
|
|
(10,101 |
) |
|
|
(3,011 |
) |
Net income |
$ |
15,164 |
|
|
$ |
7,258 |
|
|
$ |
39,856 |
|
|
$ |
10,624 |
|
Net income per common share |
|
|
|
|
|
|
|
Basic |
$ |
0.27 |
|
|
$ |
0.13 |
|
|
$ |
0.71 |
|
|
$ |
0.19 |
|
Diluted |
$ |
0.26 |
|
|
$ |
0.13 |
|
|
$ |
0.68 |
|
|
$ |
0.19 |
|
Weighted-average number of
common shares outstanding |
|
|
|
|
|
|
|
Basic |
|
56,493,757 |
|
|
|
55,785,622 |
|
|
|
56,290,195 |
|
|
|
55,658,946 |
|
Diluted |
|
59,271,757 |
|
|
|
56,579,912 |
|
|
|
58,494,045 |
|
|
|
56,029,069 |
|
THE VITA COCO COMPANY, INC. AND SUBSIDIARIES |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED) |
(Amounts in thousands) |
|
|
Nine Months Ended September 30, |
|
|
2023 |
|
|
|
2022 |
|
Cash flows from operating activities: |
|
|
|
Net income |
$ |
39,856 |
|
|
$ |
10,624 |
|
Adjustments required to reconcile net income to cash flows from
operating activities: |
|
|
|
Depreciation and amortization |
|
503 |
|
|
|
1,442 |
|
(Gain)/loss on disposal of equipment |
|
19 |
|
|
|
— |
|
Bad debt expense |
|
255 |
|
|
|
348 |
|
Unrealized (gain)/loss on derivative instruments |
|
1,758 |
|
|
|
(6,416 |
) |
Stock-based compensation |
|
7,126 |
|
|
|
5,657 |
|
Impairment loss on long-lived asset |
|
363 |
|
|
|
619 |
|
Noncash lease expense |
|
966 |
|
|
|
963 |
|
Changes in operating assets and liabilities: |
|
|
|
Accounts receivable |
|
(37,234 |
) |
|
|
(20,696 |
) |
Inventory |
|
33,815 |
|
|
|
(255 |
) |
Prepaid expenses, net supplier advances, and other assets |
|
5,215 |
|
|
|
(4,433 |
) |
Accounts payable, accrued expenses, and other liabilities |
|
17,361 |
|
|
|
(6,034 |
) |
Net cash provided by (used in) operating activities |
|
70,003 |
|
|
|
(18,181 |
) |
Cash flows from investing activities: |
|
|
|
Cash paid for property and equipment |
|
(533 |
) |
|
|
(907 |
) |
Proceeds from sale of property and equipment |
|
5 |
|
|
|
— |
|
Net cash used in investing activities |
|
(528 |
) |
|
|
(907 |
) |
Cash flows from financing activities: |
|
|
|
Proceeds from exercise of stock awards |
|
5,915 |
|
|
|
2,675 |
|
Borrowings on credit facility |
|
— |
|
|
|
22,000 |
|
Repayments of borrowings on credit facility |
|
— |
|
|
|
(12,500 |
) |
Cash received (paid) on notes payable |
|
(18 |
) |
|
|
(22 |
) |
Net cash provided by (used in) financing activities |
|
5,897 |
|
|
|
12,153 |
|
Effects of exchange rate changes on cash and cash equivalents |
|
212 |
|
|
|
(544 |
) |
Net increase/(decrease) in cash and cash equivalents |
|
75,584 |
|
|
|
(7,479 |
) |
Cash and cash equivalents at beginning of the period |
|
19,629 |
|
|
|
28,690 |
|
Cash, cash equivalents and restricted cash at end of the period
(1) |
$ |
95,213 |
|
|
$ |
21,211 |
|
1Includes $328 and $0 of restricted cash as of
September 30, 2023 and 2022, respectively, that were included
in other current assets.
RECONCILIATION FROM GAAP NET INCOME
TO NON-GAAP ADJUSTED EBITDA |
|
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|
|
2023 |
|
|
|
2022 |
|
|
2023 |
|
|
|
2022 |
|
(in thousands) |
|
|
|
|
|
|
Net income |
$ |
15,164 |
|
|
$ |
7,258 |
|
$ |
39,856 |
|
|
$ |
10,624 |
|
Depreciation and amortization |
|
163 |
|
|
|
497 |
|
|
503 |
|
|
|
1,442 |
|
Interest income |
|
(824 |
) |
|
|
(20 |
) |
|
(1,105 |
) |
|
|
(30 |
) |
Interest expense |
|
1 |
|
|
|
130 |
|
|
31 |
|
|
|
213 |
|
Income tax expense |
|
4,011 |
|
|
|
1,836 |
|
|
10,101 |
|
|
|
3,011 |
|
EBITDA |
|
18,515 |
|
|
|
9,701 |
|
|
49,386 |
|
|
|
15,260 |
|
Stock-based compensation (a) |
|
2,862 |
|
|
|
1,457 |
|
|
7,126 |
|
|
|
5,657 |
|
Unrealized (gain)/loss on derivative instruments (b) |
|
3,959 |
|
|
|
(952 |
) |
|
1,758 |
|
|
|
(6,416 |
) |
Foreign currency (gain)/loss (b) |
|
1,211 |
|
|
|
364 |
|
|
430 |
|
|
|
508 |
|
Secondary Offering Costs (c) |
|
— |
|
|
|
— |
|
|
856 |
|
|
|
— |
|
Other Adjustments (d) |
|
329 |
|
|
|
1,240 |
|
|
329 |
|
|
|
1,240 |
|
Adjusted EBITDA |
$ |
26,876 |
|
|
$ |
11,810 |
|
$ |
59,885 |
|
|
$ |
16,249 |
|
(a) |
Non-cash charges related to stock-based compensation, which vary
from period to period depending on volume and vesting timing of
awards. We adjusted for these charges to facilitate comparison from
period to period. |
(b) |
Unrealized gains or losses on
derivative instruments and foreign currency gains or losses are not
considered in our evaluation of our ongoing performance. |
(c) |
Reflects other non-recurring
expenses related to costs associated with the secondary offering in
which Verlinvest Beverages SA sold shares of the Company in an
underwritten public offering, which closed on May 26, 2023. The
Company did not receive any proceeds from the sale of the
shares. |
(d) |
Reflects other charges primarily
related to the impairment loss related to assets held for sale in
both periods and other non-recurring expenses. |
SUPPLEMENTAL INFORMATION |
|
|
NET SALES |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
(in thousands) |
2023 |
|
2022 |
|
2023 |
|
2022 |
Americas segment |
|
|
|
|
|
|
|
Vita Coco Coconut Water |
$ |
89,683 |
|
$ |
82,643 |
|
$ |
253,825 |
|
$ |
217,934 |
Private Label |
|
28,257 |
|
|
24,786 |
|
|
77,366 |
|
|
68,413 |
Other |
|
2,706 |
|
|
1,367 |
|
|
7,490 |
|
|
7,553 |
Subtotal |
|
120,646 |
|
|
108,796 |
|
|
338,681 |
|
|
293,900 |
International segment |
|
|
|
|
|
|
|
Vita Coco Coconut Water |
|
11,350 |
|
|
10,637 |
|
|
33,628 |
|
|
30,110 |
Private Label |
|
5,421 |
|
|
3,810 |
|
|
13,140 |
|
|
9,521 |
Other |
|
647 |
|
|
800 |
|
|
2,019 |
|
|
2,265 |
Subtotal |
|
17,418 |
|
|
15,247 |
|
|
48,787 |
|
|
41,896 |
Total net sales |
$ |
138,064 |
|
$ |
124,043 |
|
$ |
387,468 |
|
$ |
335,796 |
|
COST OF GOODS SOLD & GROSS PROFIT |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
(in thousands) |
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Cost of goods sold |
|
|
|
|
|
|
|
Americas segment |
$ |
70,437 |
|
|
$ |
78,516 |
|
|
$ |
214,214 |
|
|
$ |
220,615 |
|
International segment |
|
11,456 |
|
|
|
12,951 |
|
|
|
32,328 |
|
|
|
34,253 |
|
Total cost of goods sold |
$ |
81,893 |
|
|
$ |
91,467 |
|
|
$ |
246,542 |
|
|
$ |
254,868 |
|
Gross profit |
|
|
|
|
|
|
|
Americas segment |
|
50,208 |
|
|
|
30,279 |
|
|
|
124,466 |
|
|
|
73,285 |
|
International segment |
|
5,963 |
|
|
|
2,297 |
|
|
|
16,460 |
|
|
|
7,643 |
|
Total gross profit |
$ |
56,171 |
|
|
$ |
32,576 |
|
|
$ |
140,926 |
|
|
$ |
80,928 |
|
Gross margin |
|
|
|
|
|
|
|
Americas segment |
|
41.6 |
% |
|
|
27.8 |
% |
|
|
36.8 |
% |
|
|
24.9 |
% |
International segment |
|
34.2 |
% |
|
|
15.1 |
% |
|
|
33.7 |
% |
|
|
18.2 |
% |
Consolidated |
|
40.7 |
% |
|
|
26.3 |
% |
|
|
36.4 |
% |
|
|
24.1 |
% |
SUPPLEMENTAL INFORMATION |
|
|
VOLUME (CE) |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
(in thousands) |
2023 |
|
2022 |
|
2023 |
|
2022 |
Americas
segment |
|
|
|
|
|
|
|
Vita Coco Coconut Water |
9,234 |
|
8,670 |
|
26,511 |
|
23,269 |
Private Label |
3,185 |
|
2,346 |
|
8,454 |
|
7,213 |
Other |
265 |
|
200 |
|
714 |
|
1,092 |
Subtotal |
12,684 |
|
11,216 |
|
35,679 |
|
31,574 |
|
|
|
|
|
|
|
|
International
segment* |
|
|
|
|
|
|
|
Vita Coco Coconut Water |
1,504 |
|
1,581 |
|
4,665 |
|
4,412 |
Private Label |
725 |
|
492 |
|
1,766 |
|
1,326 |
Other |
10 |
|
13 |
|
46 |
|
38 |
Subtotal |
2,239 |
|
2,086 |
|
6,477 |
|
5,776 |
Total volume (CE) |
14,923 |
|
13,302 |
|
42,156 |
|
37,350 |
Note: A CE is a standard volume measure used by
management which is defined as a case of 12 bottles of 330ml liquid
beverages or the same liter volume of oil.
*International Other excludes minor volume that is
treated as zero CE
Vita Coco (NASDAQ:COCO)
Historical Stock Chart
From Apr 2024 to May 2024
Vita Coco (NASDAQ:COCO)
Historical Stock Chart
From May 2023 to May 2024